
Pandemic and All-Hazards Preparedness Act (PAHPA) Policy Brief

Estimating Long-term Economic Returns of NIH Funding on Output in the Biosciences

Comments on FDA’s Draft Guidance for Industry, Investigators, and Other Stakeholders on Decentralized Clinical Trials for Drugs, Biological Products, and Devices - Docket ID FDA-2022-D-2870
